USPTO 2015–2025 USPTO PatentsView US Corporation

Augustine Biomedical + Design, Llc

USPTO PatentsView assignee record - 77 granted patents across 25 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

27.6

Avg claims per patent

+500%

5-year filing velocity

The verdict

Augustine holds 77 US patents across 25 technology areas, rank #4,547 of 50,000 tracked assignees.

#4,547
of 50,000 US assignees by volume: Top 2%
by Innovation Score (63.2/100): 27.6
avg claims per patent: +500%
filing velocity, last 5 yrs

Portfolio overview

Augustine Biomedical + Design, Llc has been granted 77 US utility patents between 2015 and 2025, placing Augustine Biomedical + Design, Llc at rank #4,547 across all assignees tracked by PlainPatent. This portfolio spans 25 distinct Cooperative Patent Classification (CPC) subclasses, averaging 27.6 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, Augustine Biomedical + Design, Llc is one of the more focused assignees in the PatentsView dataset. By volume, Augustine sits between Whelen Engineering Company, Inc. (78 patents, rank #4,543) and Crispr Therapeutics Ag (77 patents, rank #4,551) - the closest US assignees by grant volume. The composite Innovation Score of 63.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 66 grants, compared with 11 in the 2015–2019 window, a +500% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Augustine Biomedical + Design, Llc's 27.6 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while a multi-domain presence across 25 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Augustine Biomedical + Design, Llc against peers pursuing similar technology classes.

Whelen Engineering

78
Yanshan University

78
Arlington Industr…

77
AT&T Technical Se…

77
Bizerba SE & KG

77
Berlin Heart

77
CHEP Technology P…

77
Crispr Therapeuti…

77
Augustine Biomedi… ◀

77

What this shows Augustine holds 77 patents at rank #4,547, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Augustine

By rank, the assignees closest to #4,547 in granted patent volume.

Leaders in A61B (Diagnosis)

Other assignees with the most granted patents in Augustine's primary technology class.

Augustine's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

63 Top 2% higher than 98% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Augustine Biomedical + Design, Llc patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	3.9%
2016	2	2.6%
2017	2	2.6%
2018	1	1.3%
2019	3	3.9%
2020	7	9.1%
2021	9	11.7%
2022	15	19.5%
2023	22	28.6%
2024	7	9.1%
2025	6	7.8%

Which technologies does Augustine Biomedical + Design, Llc patent most?

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 56

A61G - TRANSPORT, PERSONAL CONVEYANCES, OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS ; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES 52

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 51

B01D - SEPARATION 43

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 25

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 22

A61L - METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES 9

B32B - LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM 8

F21W - INDEXING SCHEME ASSOCIATED WITH SUBCLASSES F21K, F21L, F21S and F21V, RELATING TO USES OR APPLICATIONS OF LIGHTING DEVICES OR SYSTEMS 7

F21Y - INDEXING SCHEME ASSOCIATED WITH SUBCLASSES F21K, F21L, F21S and F21V, RELATING TO THE FORM OR THE KIND OF THE LIGHT SOURCES OR OF THE COLOUR OF THE LIGHT EMITTED 7

F21V - FUNCTIONAL FEATURES OR DETAILS OF LIGHTING DEVICES OR SYSTEMS THEREOF; STRUCTURAL COMBINATIONS OF LIGHTING DEVICES WITH OTHER ARTICLES, NOT OTHERWISE PROVIDED FOR 7

G06V - IMAGE OR VIDEO RECOGNITION OR UNDERSTANDING 7

G06F - ELECTRIC DIGITAL DATA PROCESSING 7

G06T - IMAGE DATA PROCESSING OR GENERATION, IN GENERAL 7

A62B - DEVICES, APPARATUS OR METHODS FOR LIFE-SAVING 5

Top 15 of 25 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Multi-domain

Claim Depth Complex

Velocity Accelerating

Where it ranks

Overall rank by patents

#4,547

Across all tracked assignees

Innovation Score

63.2 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Augustine Biomedical + Design, Llc hold?

Augustine Biomedical + Design, Llc holds 77 US granted patents filed between 2015 and 2025, spanning 25 technology areas.

What is Augustine Biomedical + Design, Llc's Innovation Score?

Augustine Biomedical + Design, Llc has an Innovation Score of 63.2 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Augustine Biomedical + Design, Llc focus on?

Augustine Biomedical + Design, Llc's top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 56 patents. The company has filed patents in 25 CPC subclasses total.

Is Augustine Biomedical + Design, Llc's patent filing rate increasing or decreasing?

Augustine Biomedical + Design, Llc's recent filing velocity is +500% compared to the prior five-year period. This indicates accelerating innovation.

What does claim depth mean for Augustine Biomedical + Design, Llc's patents?

Augustine Biomedical + Design, Llc's patents average 27.6 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.

How is the Augustine Biomedical + Design, Llc patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Augustine's 77 grants land it in the top 2% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Augustine ranks #4,547 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61B - see who else leads that technology area. A61B leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.